Cargando…

Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: A Study of Six Cases

PURPOSE: To report six Asian adult patients with retinoblastoma (RB). DESIGN: Retrospective and observational small case series. PARTICIPANTS: Six patients with a white dome-shaped tumor of the retina were evaluated from May 10, 1995, to September 10, 2021. MAIN OUTCOME MEASURES: Initial tumor and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Nan, Yang, Lihong, Xu, Xiaolin, Liu, Yueming, Wei, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379252/
https://www.ncbi.nlm.nih.gov/pubmed/35982972
http://dx.doi.org/10.3389/fonc.2022.835965
_version_ 1784768638490771456
author Zhou, Nan
Yang, Lihong
Xu, Xiaolin
Liu, Yueming
Wei, Wenbin
author_facet Zhou, Nan
Yang, Lihong
Xu, Xiaolin
Liu, Yueming
Wei, Wenbin
author_sort Zhou, Nan
collection PubMed
description PURPOSE: To report six Asian adult patients with retinoblastoma (RB). DESIGN: Retrospective and observational small case series. PARTICIPANTS: Six patients with a white dome-shaped tumor of the retina were evaluated from May 10, 1995, to September 10, 2021. MAIN OUTCOME MEASURES: Initial tumor and associated fundus features, pathology, gene mutation, treatment, tumor course on follow-up, and salvage globe outcome. RESULTS: The six affected Asian patients consisted of three men and three women. The mean age at the time of diagnosis was 36.5 years (median: 31 years, range: 20-55 years). All patients were unilateral. In all cases, the tumors were white, dome-shaped, with full-thickness retinal involvement, and mushroom-like protrusions into the vitreous cavity. The mean tumor thickness measured by ultrasonography was 4.5 mm (median: 3.2 mm, range: 3.2-6.8 mm). Associated characteristic symptoms included dilated retinal feeding artery and draining vein (100%), surrounding subretinal infiltration (83%), exudative retinal detachment (83%), and vitreous seeds (67%). Local tumor resection was performed in three patients, I-125 plaque brachytherapy combined with transpupillary thermotherapy (TTT) and intravitreous injection of melphalan (combination treatment) in one patient, I-125 plaque brachytherapy in two patients, and enucleation in one (20%) patient. RB1 gene testing was carried out on four patients and pathological diagnosis on five patients. Genetic analysis revealed that the RB1 mutation was a mosaic c.709dupG (p.Glu237GlyfsTer4) duplication in one patient, a mosaic c.763C>T(p.Arg255Ter) mutation in another patient, while the remaining two patients were RB1 negative. At the end of the follow-up, none of the patients had developed tumor-related metastasis or died. The findings were consistent in all patients who had an adequate follow-up. This study focused on this rare lesion to distinguish it from other intraocular white lesions in adults, including choroidal osteoma, vitreoretinal lymphoma, and retinal capillary hemangioma, all of which are different clinical entities. CONCLUSION: In adults, RB is typically a white, full-thickness retinal mass that is unilateral, often combining with retinal feeding vessels, subretinal infiltration, and vitreous seeds. Genetic studies on adult-onset RB are essential and still require elucidation. Despite RB being a malignant tumor, patient survival was minimally affected.
format Online
Article
Text
id pubmed-9379252
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93792522022-08-17 Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: A Study of Six Cases Zhou, Nan Yang, Lihong Xu, Xiaolin Liu, Yueming Wei, Wenbin Front Oncol Oncology PURPOSE: To report six Asian adult patients with retinoblastoma (RB). DESIGN: Retrospective and observational small case series. PARTICIPANTS: Six patients with a white dome-shaped tumor of the retina were evaluated from May 10, 1995, to September 10, 2021. MAIN OUTCOME MEASURES: Initial tumor and associated fundus features, pathology, gene mutation, treatment, tumor course on follow-up, and salvage globe outcome. RESULTS: The six affected Asian patients consisted of three men and three women. The mean age at the time of diagnosis was 36.5 years (median: 31 years, range: 20-55 years). All patients were unilateral. In all cases, the tumors were white, dome-shaped, with full-thickness retinal involvement, and mushroom-like protrusions into the vitreous cavity. The mean tumor thickness measured by ultrasonography was 4.5 mm (median: 3.2 mm, range: 3.2-6.8 mm). Associated characteristic symptoms included dilated retinal feeding artery and draining vein (100%), surrounding subretinal infiltration (83%), exudative retinal detachment (83%), and vitreous seeds (67%). Local tumor resection was performed in three patients, I-125 plaque brachytherapy combined with transpupillary thermotherapy (TTT) and intravitreous injection of melphalan (combination treatment) in one patient, I-125 plaque brachytherapy in two patients, and enucleation in one (20%) patient. RB1 gene testing was carried out on four patients and pathological diagnosis on five patients. Genetic analysis revealed that the RB1 mutation was a mosaic c.709dupG (p.Glu237GlyfsTer4) duplication in one patient, a mosaic c.763C>T(p.Arg255Ter) mutation in another patient, while the remaining two patients were RB1 negative. At the end of the follow-up, none of the patients had developed tumor-related metastasis or died. The findings were consistent in all patients who had an adequate follow-up. This study focused on this rare lesion to distinguish it from other intraocular white lesions in adults, including choroidal osteoma, vitreoretinal lymphoma, and retinal capillary hemangioma, all of which are different clinical entities. CONCLUSION: In adults, RB is typically a white, full-thickness retinal mass that is unilateral, often combining with retinal feeding vessels, subretinal infiltration, and vitreous seeds. Genetic studies on adult-onset RB are essential and still require elucidation. Despite RB being a malignant tumor, patient survival was minimally affected. Frontiers Media S.A. 2022-08-02 /pmc/articles/PMC9379252/ /pubmed/35982972 http://dx.doi.org/10.3389/fonc.2022.835965 Text en Copyright © 2022 Zhou, Yang, Xu, Liu and Wei https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhou, Nan
Yang, Lihong
Xu, Xiaolin
Liu, Yueming
Wei, Wenbin
Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: A Study of Six Cases
title Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: A Study of Six Cases
title_full Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: A Study of Six Cases
title_fullStr Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: A Study of Six Cases
title_full_unstemmed Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: A Study of Six Cases
title_short Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: A Study of Six Cases
title_sort retinoblastoma in adults: clinical features, gene mutations and treatment outcomes: a study of six cases
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379252/
https://www.ncbi.nlm.nih.gov/pubmed/35982972
http://dx.doi.org/10.3389/fonc.2022.835965
work_keys_str_mv AT zhounan retinoblastomainadultsclinicalfeaturesgenemutationsandtreatmentoutcomesastudyofsixcases
AT yanglihong retinoblastomainadultsclinicalfeaturesgenemutationsandtreatmentoutcomesastudyofsixcases
AT xuxiaolin retinoblastomainadultsclinicalfeaturesgenemutationsandtreatmentoutcomesastudyofsixcases
AT liuyueming retinoblastomainadultsclinicalfeaturesgenemutationsandtreatmentoutcomesastudyofsixcases
AT weiwenbin retinoblastomainadultsclinicalfeaturesgenemutationsandtreatmentoutcomesastudyofsixcases